How We Think - Merck

These are the posts from the How we think section that have been tagged with Merck.

To see all tags used in our posts, click here.

chessboard-strategy-photo

Marketing strategy in complex environments

Mark Assenti, Kulveer Singh|19th September 2016

Age-old treatment protocols are being replaced with new and innovative treatment paradigms that will revolutionise the healthcare industry for years to come. Kulveer Singh and Mark Assenti talk through what this means for pharma strategists and their product lines.

read more

Stumble-but-not-a-fall-whats-next-for-opdivo-feature-image

A stumble, but not a fall – what’s next for Opdivo?

Louis Perdios|24th August 2016

In this article, Associate Consultant Louis Perdios talks about the immunotherapy drug Opdivo and the daunting challenges faced by BMS after disappointing results. However the future for Opdivo may not be as bleak as it seems. 

 

read more

surfing-healthcare-disruption-tsunami-blue-latitude-health

How to surf the healthcare disruption tsunami

James Atherton|12th January 2016

Moving into 2016, we want to draw the focus to the issue of tangibly defining value in healthcare innovation and ensuring that the services that pharma and healthcare brands are developing are actually taken up and implemented. Managing Consultant James Atherton talks through some tangible tips for businesses and brands looking to surf the wave of disruption in 2016.

read more